Our data suggest that the proportion of IL-8+ naïve T cells reflects intratumorous thymopoiesis and naïve T-cell outputs from thymic tumors, and thus IL-8 may emerge as a biomarker candidate for differential diagnosis of thymic tumors. This evidence concerns the gene CXCL8 and thymus neoplasm.